Key result
Transcatheter mitral valve interventions have expanded the treatment options for patients with mitral regurgitation who are ineligible for traditional surgery due to age and comorbidities.
Why the study?
Many patients with mitral regurgitation are ineligible for surgery due to age and comorbidities, and percutaneous interventions have emerged to address this untreated group.
This review summarizes recent and established developments in transcatheter mitral valve interventions for patients ineligible for surgery.
Expands percutaneous options for high-risk mitral regurgitation patients; leaves open optimal selection and long-term durability.
Mitral regurgitation is a common valvular heart disorder increasing with age. Many patients are ineligible for mitral valve surgery due to their age and other comorbidities. Left untreated, patients develop severe disease with a poor prognosis. The development of lower risk percutaneous mitral valve interventions has helped meet the needs of this previously untreated patient group. This review explores the recent and more established developments that have expanded the armamentarium for transcatheter mitral valve intervention.
No takes yet. Share an insight, caveat, or question.
Ganatra et al. (2021) conducted a review in Mitral regurgitation. Transcatheter mitral valve intervention was evaluated. Transcatheter mitral valve interventions have expanded the treatment options for patients with mitral regurgitation who are ineligible for traditional surgery due to age and comorbidities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: